Shrink Nanotechnologies, Inc., revolutionary developers of nanotech solutions based on innovations developed by Dr. Michelle Khine, announced the inception of a sponsored 3-year research agreement with California’s largest public university system today.

Dr. Khine’s innovations have become the core technology behind the Company’s NanoShrink™ plastic substrate, which uses the technology to rapid-manufacture complex nanostructures from shrinkable polystyrene via the patent-pending ShrinkChip Manufacturing Solution™ process (with current primary applications in biological/environmental sensing tools and full-spectrum solar cells).

CEO of INKN, Mark L. Baum, noted the importance of the Company’s integrated FIGA (finance, industry, government and academia) model, which offers superior public university asset leveraging capabilities, tapping into the facilities and minds of this underutilized resource to generate relationships and an advanced R&D infrastructure via the assemblage of a network of brilliant minds intent on quantifying commercial pathways into several large and rapidly growing markets for the Company’s core technologies.

The project is designed with just such objectives in mind, and the ultimate goal is to produce a series of ultra-functional nano-chips/devices for immunoassay substrate, biotech and stem cell applications, which will be able to assess discrete phenomenology and reveal if an individual has had a heart attack, or shows signs of cancer, or even to test for water-borne contaminates like arsenic.

The real beauty of this specific agreement is that the Company managed to negotiate terms which conferred intellectual property rights predating the agreement, thus giving INKN exclusive access to inventions developed from as far back as mid-09. This results in a huge boon for the Company and its shareholders which will surely enable them to acquire long-term “financially accretive intellectual property assets” – resulting in rights to highly marketable products that really “make a difference in people’s lives”.

The Company is also actively engaged in revolutionary solar work that has produced a system based on their core nanotech which can utilize the full spectrum of light energy at a higher level of efficiency and yet is able to be incorporated anywhere, even into clothing. The solar concentrators being developed offer the promise of making renewable/sustainable solar energy an economically viable solution which does not require public-sector capital.